WI
EW icon

Wafra Inc’s Edwards Lifesciences EW Stock Holding History

Wafra Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-122,973
Closed -$9.18M – 64
2022
Q4 		$9.18M Hold
122,973
– – 0.35% 57
2022
Q3 		$10.2M Buy
122,973
+1,213
+1% +$117K 0.4% 59
2022
Q2 		$11.6M Sell
121,760
-359,822
-75% -$37.3M 0.44% 53
2022
Q1 		$56.7M Buy
481,582
+3,413
+0.7% +$383K 1.96% 17
2021
Q4 		$61.9M Sell
478,169
-254,617
-35% -$29.7M 1.96% 18
2021
Q3 		$83M Sell
732,786
-8,595
-1% -$981K 3.04% 8
2021
Q2 		$76.8M Buy
741,381
+9,011
+1% +$849K 2.89% 7
2021
Q1 		$61.3M Buy
732,370
+242,843
+50% +$20.5M 2.55% 11
2020
Q4 		$44.7M Buy
489,527
+50,350
+11% +$4.18M 1.99% 17
2020
Q3 		$35.1M Buy
439,177
+77,846
+22% +$6.07M 1.98% 14
2020
Q2 		$25M Buy
+361,331
New +$25.7M 1.58% 23

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Wafra Inc's EW Position: Q1 2023 in Review

Wafra Inc sold out of Edwards Lifesciences (EW) in Q1 2023, closing a stake of 122,973 shares — an estimated $9.18M sold.

Wafra Inc first reported a position in EW in Q2 2020 and held it in 11 quarters. The position peaked at $83M in Q3 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q1 2023.

  • Wafra Inc reported no remaining Edwards Lifesciences position as of Q1 2023 after selling out during the quarter.
  • Wafra Inc sold 122,973 Edwards Lifesciences shares in Q1 2023, an estimated $9.18M.
  • Wafra Inc first reported a position in Edwards Lifesciences in Q2 2020 and held it in 11 quarters.
  • Wafra Inc's Edwards Lifesciences position peaked at $83M in Q3 2021.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on Wafra Inc's 13F filing for Q1 2023, filed 4 May 2023.